1.37
price down icon0.72%   -0.010
after-market Dopo l'orario di chiusura: 1.36 -0.01 -0.73%
loading
Precedente Chiudi:
$1.38
Aprire:
$1.34
Volume 24 ore:
389.30K
Relative Volume:
2.15
Capitalizzazione di mercato:
$57.39M
Reddito:
$9.16M
Utile/perdita netta:
$-68.17M
Rapporto P/E:
-0.8405
EPS:
-1.63
Flusso di cassa netto:
$-80.16M
1 W Prestazione:
+8.73%
1M Prestazione:
+0.00%
6M Prestazione:
-8.67%
1 anno Prestazione:
-17.96%
Intervallo 1D:
Value
$1.30
$1.39
Intervallo di 1 settimana:
Value
$1.20
$1.40
Portata 52W:
Value
$0.9707
$1.94

Ikena Oncology Inc Stock (IKNA) Company Profile

Name
Nome
Ikena Oncology Inc
Name
Telefono
857-343-8292
Name
Indirizzo
50 NORTHERN AVE., BOSTON
Name
Dipendente
9
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
IKNA's Discussions on Twitter

Confronta IKNA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
IKNA
Ikena Oncology Inc
1.37 51.94M 9.16M -68.17M -80.16M -1.63
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Ikena Oncology Inc Stock (IKNA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-05-29 Downgrade Wedbush Outperform → Neutral
2023-09-22 Iniziato Wedbush Outperform
2023-05-04 Ripresa H.C. Wainwright Buy
2021-12-23 Iniziato H.C. Wainwright Buy
2021-05-05 Ripresa Credit Suisse Outperform
2021-04-26 Ripresa Credit Suisse Outperform
2021-04-20 Iniziato Credit Suisse Outperform
2021-04-20 Iniziato Jefferies Buy
2021-04-20 Iniziato William Blair Outperform
Mostra tutto

Ikena Oncology Inc Borsa (IKNA) Ultime notizie

pulisher
Jul 24, 2025

What analysts say about Ikena Oncology Inc. stockHigh-impact stock picks - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Ikena Oncology, Inc. SEC 10-Q Report - TradingView

Jul 24, 2025
pulisher
Jul 24, 2025

Ikena Oncology shares climb as Kristin Yarema named CEO of soon-to-merge ImageneBio - MSN

Jul 24, 2025
pulisher
Jul 24, 2025

Ikena Oncology to implement 1-for-12 reverse stock split and rebrand as ImageneBio By Investing.com - Investing.com South Africa

Jul 24, 2025
pulisher
Jul 24, 2025

Ikena Oncology Announces Reverse Stock Split and Rebrand - TipRanks

Jul 24, 2025
pulisher
Jul 24, 2025

Ikena to Rebrand as ImageneBio, Start 1-for-12 Reverse Split 28 Jul 2025 | IKNA SEC FilingForm 8-K - Stock Titan

Jul 24, 2025
pulisher
Jul 23, 2025

Ikena Oncology and Inmagene Biopharmaceuticals Announce - GlobeNewswire

Jul 23, 2025
pulisher
Jul 23, 2025

Kristin Yarema to lead merged Inmagene-Ikena entity - BioCentury

Jul 23, 2025
pulisher
Jul 23, 2025

Ikena Oncology stock rises after naming Kristin Yarema as CEO of combined company - Investing.com India

Jul 23, 2025
pulisher
Jul 23, 2025

Ikena Oncology and Inmagene Biopharmaceuticals Announce Kristin Yarema, Ph.D., as Chief Executive Officer of Merged Company - The Manila Times

Jul 23, 2025
pulisher
Jul 23, 2025

Ikena Oncology and Inmagene name Kristin Yarema as CEO of combined firm By Investing.com - Investing.com South Africa

Jul 23, 2025
pulisher
Jul 23, 2025

Roche-Acquired Poseida CEO Takes Helm at Ikena-Inmagene Merger with $75M Funding - Stock Titan

Jul 23, 2025
pulisher
Jul 23, 2025

Ikena Oncology Inc. Stock Analysis and ForecastRemarkable growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Ikena Oncology Announces Merger with Inmagene - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

IKNA issues special CVR dividend ahead of Inmagene merger | IKNA SEC FilingForm 8-K - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Ikena Oncology Inc. stock priceBreakneck growth rates - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Ikena Oncology Inc. a good long term investmentBreakthrough stock performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 16, 2025

Ikena Oncology Approves Merger and Reverse Stock Split - The Globe and Mail

Jul 16, 2025
pulisher
Jul 16, 2025

Ikena Oncology amends executive agreement with Dr. Jotin Marango for equity vesting - Investing.com Nigeria

Jul 16, 2025
pulisher
Jul 16, 2025

Ikena Oncology amends executive agreement with Dr. Jotin Marango for equity vesting By Investing.com - Investing.com South Africa

Jul 16, 2025
pulisher
Jul 16, 2025

Ikena Oncology Updates Employment Terms Amid Merger Plans - TipRanks

Jul 16, 2025
pulisher
Jul 16, 2025

Ikena Oncology Announces Stockholder Approval of Merger with Inmagene Biopharmaceuticals - GlobeNewswire

Jul 16, 2025
pulisher
Jul 15, 2025

How Ikena Oncology Inc. stock performs during market volatilityIntraday Trade Ideas - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Ikena Oncology announces stockholder approval of merger with Inmagene Biopharmaceuticals - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Ikena shareholders approve merger with Inmagene, reverse stock split - Investing.com Australia

Jul 15, 2025
pulisher
Jul 15, 2025

Ikena announces 1-for-12 reverse stock split, approval of Inmagene merger - TipRanks

Jul 15, 2025
pulisher
Jul 15, 2025

Ikena shareholders approve merger with Inmagene, reverse stock split By Investing.com - Investing.com Nigeria

Jul 15, 2025
pulisher
Jul 15, 2025

Ikena Oncology Approves Merger with Inmagene Biopharmaceuticals - AInvest

Jul 15, 2025
pulisher
Jul 15, 2025

Ikena Oncology Shareholders Green Light Inmagene Merger: What the 1-for-12 Split Means for Investors - Stock Titan

Jul 15, 2025
pulisher
Jul 15, 2025

Why Ikena Oncology Inc. stock attracts strong analyst attentionFree Best Performing Stock Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Ikena Oncology Inc. stock price move sharplyFree Stock Market Real-Time Monitoring - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Ikena Oncology Merger Recommended by Shareholder Services - The Globe and Mail

Jul 12, 2025
pulisher
Jul 11, 2025

SBET spends $25.7M on 10,000 ETH; Share-reserve waiver opens ATM issuances | IKNA SEC FilingForm 8-K - Stock Titan

Jul 11, 2025
pulisher
Jul 11, 2025

Ikena Oncology Announces Support from ISS and Glass Lewis for Shareholder Vote on Inmagene Merger - Nasdaq

Jul 11, 2025
pulisher
Jul 11, 2025

Ikena Oncology Announces ISS and Glass Lewis Recommend - GlobeNewswire

Jul 11, 2025
pulisher
Jul 09, 2025

Ikena Oncology (NASDAQ:IKNA) Stock Price Up 1.5% – Here’s Why - Defense World

Jul 09, 2025

Ikena Oncology Inc Azioni (IKNA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):